Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2026

The following table provides a reconciliation of cash, cash equivalents and restricted cash presented on our balance sheets to amounts shown in our condensed consolidated statements of cash flows:


	As of September 30,
	2026		2025
	(in thousands)
Cash and cash equivalents	$	6,126	$	3,531
Restricted cash – current	5,506		5,346
Restricted cash – noncurrent	18,979		14,574
Total cash, cash equivalents and restricted cash	$	30,611	$	23,451

Schedule of Restricted Cash and Restricted Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash presented on our balance sheets to amounts shown in our condensed consolidated statements of cash flows:


	As of September 30,
	2026		2025
	(in thousands)
Cash and cash equivalents	$	6,126	$	3,531
Restricted cash – current	5,506		5,346
Restricted cash – noncurrent	18,979		14,574
Total cash, cash equivalents and restricted cash	$	30,611	$	23,451

Schedule of Supplemental Cash Flow

The following are our supplemental cash flow disclosures for the nine months ended September 30, 2026 and 2025:


	Nine Months Ended September 30,
		2026		2025
	(in thousands)
Supplemental cash flow disclosures:
Interest paid, net of amounts capitalized		$	298,455	$	228,495
Income tax payments (refunds)		719		8,847
Non-cash investing and financing activities:
Capital expenditures included in accounts payable and accrued liabilities		$	169,892	$	164,045

Equity consideration for acquisitions		—		82,145
Vital purchase price allocation adjustment		6,951		—
Right-of-use assets obtained in exchange for leases		63,433		13,669